Factor viii recomb novoeight
Products billed under this code include Novoeight.
Payment limit per 1 IU, by effective quarter, 1Q21 to 4Q26. Gaps mean the code was not in that quarter’s file, or CMS gave no payment limit.Products billed under this code include Novoeight.
Payment limit per 1 IU, by effective quarter, 1Q21 to 4Q26. Gaps mean the code was not in that quarter’s file, or CMS gave no payment limit.From the 4Q26 NDC–HCPCS crosswalk. “Limit / pkg” is the 4Q26 payment limit times the billing units in one package.
| Product | Labeler | NDC | Units / pkg | Limit / pkg |
|---|---|---|---|---|
| Novoeight | Novo Nordisk, Inc | 00169-7810-01 | 1 | $1.557 |
| Novoeight | Novo Nordisk, Inc | 00169-7815-01 | 1 | $1.557 |
| Novoeight | Novo Nordisk, Inc | 00169-7820-01 | 1 | $1.557 |
| Novoeight | Novo Nordisk, Inc | 00169-7825-01 | 1 | $1.557 |
| Novoeight | Novo Nordisk, Inc | 00169-7830-01 | 1 | $1.557 |
| Novoeight | Novo Nordisk, Inc | 00169-7850-01 | 1 | $1.557 |
| Quarter | Payment limit | Change | Billing unit | Description | Source file |
|---|---|---|---|---|---|
| 4Q26 | $1.557 | +$0.114 | 1 IU | Factor viii recomb novoeight | v1, posted September 17, 2026 |
| 3Q26 | $1.443 | +$0.033 | 1 IU | Factor viii recomb novoeight | v1, posted September 15, 2026 |
| 2Q26 | $1.41 | −$0.141 | 1 IU | Factor viii recomb novoeight | v1, posted September 15, 2026 |
| 1Q26 | $1.551 | +$0.012 | 1 IU | Factor viii recomb novoeight | v1, posted September 15, 2026 |
| 4Q25 | $1.539 | +$0.022 | 1 IU | Factor viii recomb novoeight | v1, posted September 8, 2026 |
| 3Q25 | $1.517 | +$0.12 | 1 IU | Factor viii recomb novoeight | v1, posted March 10, 2026 |
| 2Q25 | $1.397 | −$0.03 | 1 IU | Factor viii recomb novoeight | v1, posted March 10, 2026 |
| 1Q25 | $1.427 | +$0.049 | 1 IU | Factor viii recomb novoeight | v1, posted December 19, 2025 |
| 4Q24 | $1.378 | +$0.002 | 1 IU | Factor viii recomb novoeight | v1, posted June 11, 2025 |
| 3Q24 | $1.376 | −$0.001 | 1 IU | Factor viii recomb novoeight | v1, posted June 11, 2025 |
| 2Q24 | $1.377 | +$0.038 | 1 IU | Factor viii recomb novoeight | v1, posted March 11, 2025 |
| 1Q24 | $1.339 | +$0.03 | 1 IU | Factor viii recomb novoeight | v1, posted December 19, 2024 |
| 4Q23 | $1.309 | +$0.026 | 1 IU | Factor viii recomb novoeight | v1, posted October 10, 2024 |
| 3Q23 | $1.283 | +$0.031 | 1 IU | Factor viii recomb novoeight | v1, posted June 5, 2024 |
| 2Q23 | $1.252 | +$0.168 | 1 IU | Factor viii recomb novoeight | v1, posted February 23, 2024 |
| 1Q23 | $1.084 | −$0.048 | 1 IU | Factor viii recomb novoeight | v1, posted December 6, 2023 |
| 4Q22 | $1.132 | −$0.129 | 1 IU | Factor viii recomb novoeight | v1, posted June 22, 2023 |
| 3Q22 | $1.261 | −$0.031 | 1 IU | Factor viii recomb novoeight | v1, posted June 9, 2023 |
| 2Q22 | $1.292 | −$0.233 | 1 IU | Factor viii recomb novoeight | v1, posted December 14, 2022 |
| 1Q22 | $1.525 | +$0.02 | 1 IU | Factor viii recomb novoeight | v1, posted June 8, 2022 |
| 4Q21 | $1.505 | +$0.177 | 1 IU | Factor viii recomb novoeight | v1, posted June 2, 2022 |
| 3Q21 | $1.328 | +$0.078 | 1 IU | Factor viii recomb novoeight | v1, posted June 2, 2022 |
| 2Q21 | $1.25 | −$0.038 | 1 IU | Factor viii recomb novoeight | v1, posted March 1, 2022 |
| 1Q21 | $1.288 | – | 1 IU | Factor viii recomb novoeight | v1, posted December 10, 2021 |
“Change” is the difference from the previous quarter, shown only when both quarters have a payment limit and the billing unit is the same. “vs. last quarter” and “vs. a year ago” follow the same rule.